CHICAGO, Sept. 4, 2019 /PRNewswire/ -- Innoblative Designs, Inc. (Innoblative), a private medical device company committed to developing next generation, advanced-ener

NYSE | TSX : ACB EDMONTON, Sept. 4, 2019 /PRNewswire/ - Aurora Cannabis Inc. ("Aurora or the "Company") (NYSE | TSX: ACB), the Canadian company defining the future of cannabis worldwide, announced today that on September 3, 2019, Aurora disposed of its remaining 28,833,334 shares, representing 10.5% of the issued and outstanding

BURLINGTON, ON, Sept. 4, 2019 /PRNewswire/ - Rapid Dose Therapeutics Corp. ("RDT") (CSE: DOSE) announced today that the

SAN FRANCISCO, Sept. 4, 2019 /PRNewswire/ -- Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage biotechnology company developing transformational treatments for patients with non-alcoholic steatohepatitis (NASH) and other serious metabolic disorders, today announced that members of the management team will provide a business overview and update at t

ROCKVILLE, Md. and ALPHARETTA, Ga., Sept. 4, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy based on its proprietary NAV® Technology Platform, and Clearside Biomedical, Inc. (Nasdaq: CLSD), a biop

PHILADELPHIA and BOSTON, Sept. 4, 2019 /PRNewswire/ -- Pareto Health, Inc. ("Pareto Health"), a leading employee benefit group captive manager that hel

JERSEY CITY, N.J., Sept. 4, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced that the Company will present in the following investor conferences:The H.C. Wainwright Global Investment Conference at the Lotte New Yo

SOUTH SAN FRANCISCO, Calif., Sept. 4, 2019 /PRNewswire/ -- Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, CEO of Sutro Biopharma, will present a corporate overview at the H.C. Wainwright 21st Annual Healthcare Conference on Tuesday, Sept. 10, 2019, at 11:40 AM EDT, in

CAMBRIDGE, Mass., Sept. 4, 2019 /PRNewswire/ -- Leap Therapeutics, Inc. (NASDAQ: LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today announced that Christopher K. Mirabelli, Ph.D., Chairman, President and Chief Executive Officer, will present a corporate overview at the following investor conferen

Line of Reinforcement Devices for Hernia and Abdominal Wall Repair to be Introduced at Canadian Surgery Forum COLUMBIA, Md., Sept. 4, 2019 /PRNewswire/ -- ACell, Inc. and Southmedic today announced the Canadian launch of the GentrixTM Surgical Matrix family of devices, comprised of ACell's platform MatriStem UBM™ (Urinary Bladder Matrix) t